19-42334083-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001271938.2(MEGF8):c.428C>T(p.Pro143Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P143Q) has been classified as Likely benign.
Frequency
Consequence
NM_001271938.2 missense
Scores
Clinical Significance
Conservation
Publications
- MEGF8-related Carpenter syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- Carpenter syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MEGF8 | ENST00000251268.11 | c.428C>T | p.Pro143Leu | missense_variant | Exon 3 of 42 | 5 | NM_001271938.2 | ENSP00000251268.5 | ||
| MEGF8 | ENST00000334370.8 | c.428C>T | p.Pro143Leu | missense_variant | Exon 3 of 41 | 1 | ENSP00000334219.4 | |||
| MEGF8 | ENST00000378073.5 | c.-6658C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 3 of 41 | 5 | ENSP00000367313.4 | ||||
| MEGF8 | ENST00000378073.5 | c.-6658C>T | 5_prime_UTR_variant | Exon 3 of 41 | 5 | ENSP00000367313.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 247972 AF XY: 0.00000742 show subpopulations
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461268Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 726950 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
MEGF8-related Carpenter syndrome Uncertain:1
This sequence change replaces proline with leucine at codon 143 of the MEGF8 protein (p.Pro143Leu). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs765654107, ExAC 0.009%). This variant has not been reported in the literature in individuals affected with MEGF8-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.428C>T (p.P143L) alteration is located in exon 3 (coding exon 3) of the MEGF8 gene. This alteration results from a C to T substitution at nucleotide position 428, causing the proline (P) at amino acid position 143 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at